126 related articles for article (PubMed ID: 10590264)
1. Allelic variations in rat MHC class II binding of myelin basic protein peptides correlate with encephalitogenicity.
de Graaf KL; Weissert R; Kjellén P; Holmdahl R; Olsson T
Int Immunol; 1999 Dec; 11(12):1981-8. PubMed ID: 10590264
[TBL] [Abstract][Full Text] [Related]
2. MHC class II-regulated central nervous system autoaggression and T cell responses in peripheral lymphoid tissues are dissociated in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Weissert R; de Graaf KL; Storch MK; Barth S; Linington C; Lassmann H; Olsson T
J Immunol; 2001 Jun; 166(12):7588-99. PubMed ID: 11390515
[TBL] [Abstract][Full Text] [Related]
3. Major histocompatibility complex-controlled protective influences on experimental autoimmune encephalomyelitis are peptide specific.
Issazadeh S; Kjellén P; Olsson T; Mustafa M; Holmdahl R
Eur J Immunol; 1997 Jun; 27(6):1584-7. PubMed ID: 9209515
[TBL] [Abstract][Full Text] [Related]
4. The major histocompatibility complex influences myelin basic protein 63-88-induced T cell cytokine profile and experimental autoimmune encephalomyelitis.
Mustafa M; Vingsbo C; Olsson T; Ljungdahl A; Höjeberg B; Holmdahl R
Eur J Immunol; 1993 Dec; 23(12):3089-95. PubMed ID: 7504988
[TBL] [Abstract][Full Text] [Related]
5. Protective influences on experimental autoimmune encephalomyelitis by MHC class I and class II alleles.
Mustafa M; Vingsbo C; Olsson T; Issazadeh S; Ljungdahl A; Holmdahl R
J Immunol; 1994 Oct; 153(7):3337-44. PubMed ID: 7522259
[TBL] [Abstract][Full Text] [Related]
6. Disparate MHC class II haplotypes in myelin oligodendrocyte glycoprotein- and myelin basic protein-induced experimental autoimmune encephalomyelitis.
Muhallab S; Dahlman I; Wallström E
J Neuroimmunol; 2005 Apr; 161(1-2):155-61. PubMed ID: 15748954
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of peptides from myelin basic protein binding to the MHC class II protein, I-Au, which confers susceptibility to experimental allergic encephalomyelitis.
Fugger L; Liang J; Gautam A; Rothbard JB; McDevitt HO
Mol Med; 1996 Mar; 2(2):181-8. PubMed ID: 8726461
[TBL] [Abstract][Full Text] [Related]
8. MHC class II isotype- and allele-specific attenuation of experimental autoimmune encephalomyelitis.
de Graaf KL; Barth S; Herrmann MM; Storch MK; Otto C; Olsson T; Melms A; Jung G; Wiesmüller KH; Weissert R
J Immunol; 2004 Aug; 173(4):2792-802. PubMed ID: 15294998
[TBL] [Abstract][Full Text] [Related]
9. CDR3 sequence preference of TCRBV8S2+ T cells within the CNS does not reflect single amino acid dependent avidity expansion.
de Graaf KL; Berne GP; Herrmann MM; Hansson GK; Olsson T; Weissert R
J Neuroimmunol; 2005 Sep; 166(1-2):47-54. PubMed ID: 15963573
[TBL] [Abstract][Full Text] [Related]
10. Experimental autoimmune encephalomyelitis-resistant mice have highly encephalitogenic myelin basic protein (MBP)-specific T cell clones that recognize a MBP peptide with high affinity for MHC class II.
Abromson-Leeman S; Alexander J; Bronson R; Carroll J; Southwood S; Dorf M
J Immunol; 1995 Jan; 154(1):388-98. PubMed ID: 7527816
[TBL] [Abstract][Full Text] [Related]
11. High affinity for class II molecules as a necessary but not sufficient characteristic of encephalitogenic determinants.
Wall M; Southwood S; Sidney J; Oseroff C; del Guericio MF; Lamont AG; Colón SM; Arrhenius T; Gaeta FC; Sette A
Int Immunol; 1992 Jul; 4(7):773-7. PubMed ID: 1379827
[TBL] [Abstract][Full Text] [Related]
12. Two-domain MHC class II molecules form stable complexes with myelin basic protein 69-89 peptide that detect and inhibit rat encephalitogenic T cells and treat experimental autoimmune encephalomyelitis.
Burrows GG; Bebo BF; Adlard KL; Vandenbark AA; Offner H
J Immunol; 1998 Dec; 161(11):5987-96. PubMed ID: 9834080
[TBL] [Abstract][Full Text] [Related]
13. Definition of an extended MHC class II-peptide binding motif for the autoimmune disease-associated Lewis rat RT1.BL molecule.
Wauben MH; van der Kraan M; Grosfeld-Stulemeyer MC; Joosten I
Int Immunol; 1997 Feb; 9(2):281-90. PubMed ID: 9040010
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of entire myelin basic protein-induced experimental autoimmune encephalomyelitis in Lewis rats by major histocompatibility complex class II-binding competitor peptides.
Wauben MH; Kozhich A; Joosten I; Schlief A; Boog CJ; van Eden W
Eur J Immunol; 1994 May; 24(5):1053-60. PubMed ID: 7514128
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with peptides from MHC class II beta chain hypervariable region causes allele-specific suppression of EAE.
Bright JJ; Topham DJ; Nag B; Lodge PA; Sriram S
J Neuroimmunol; 1996 Jul; 67(2):119-24. PubMed ID: 8765334
[TBL] [Abstract][Full Text] [Related]
16. Subtle effects on myelin basic protein-specific T cell responses can lead to a major reduction in disease susceptibility in experimental allergic encephalomyelitis.
Vowles C; Chan VS; Bodmer HC
J Immunol; 2000 Jul; 165(1):75-82. PubMed ID: 10861037
[TBL] [Abstract][Full Text] [Related]
17. Binding of copolymer 1 and myelin basic protein leads to clustering of class II MHC molecules on antigen-presenting cells.
Fridkis-Hareli M; Teitelbaum D; Pecht I; Arnon R; Sela M
Int Immunol; 1997 Jul; 9(7):925-34. PubMed ID: 9237101
[TBL] [Abstract][Full Text] [Related]
18. Identification of an Mhc-DPB1 allele involved in susceptibility to experimental autoimmune encephalomyelitis in rhesus macaques.
Slierendregt BL; Hall M; 't Hart B; Otting N; Anholts J; Verduin W; Claas F; Jonker M; Lanchbury JS; Bontrop RE
Int Immunol; 1995 Oct; 7(10):1671-9. PubMed ID: 8562513
[TBL] [Abstract][Full Text] [Related]
19. Minimum structural requirements for peptide presentation by major histocompatibility complex class II molecules: implications in induction of autoimmunity.
Gautam AM; Lock CB; Smilek DE; Pearson CI; Steinman L; McDevitt HO
Proc Natl Acad Sci U S A; 1994 Jan; 91(2):767-71. PubMed ID: 7507253
[TBL] [Abstract][Full Text] [Related]
20. Rat RT1.B-transfected fibroblast lines process and present myelin antigens and activate T cells to induce experimental autoimmune encephalomyelitis.
Buenafe AC; Tsu RC; McMahan R; Bebo BF; Vandenbark AA; Offner H
J Neuroimmunol; 2001 Jan; 112(1-2):106-14. PubMed ID: 11108939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
